Literature DB >> 18223176

Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD).

Courtney D Fitzhugh, Shira Perl, Matthew M Hsieh.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18223176      PMCID： PMC2214764          DOI： 10.1182/blood-2007-10-118257

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Nonmalignant late effects after allogeneic stem cell transplantation.

Authors:  Gérard Socié; Nina Salooja; Amnon Cohen; Attilio Rovelli; Enric Carreras; Anna Locasciulli; Elisabeth Korthof; Joachim Weis; Vincent Levy; André Tichelli
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

2.  Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease.

Authors:  M C Walters; R Storb; M Patience; W Leisenring; T Taylor; J E Sanders; G E Buchanan; Z R Rogers; P Dinndorf; S C Davies; I A Roberts; R Dickerhoff; A M Yeager; L Hsu; J Kurtzberg; K Ohene-Frempong; N Bunin; F Bernaudin; W Y Wong; J P Scott; D Margolis; E Vichinsky; D A Wall; A S Wayne; C Pegelow; R Redding-Lallinger; J Wiley; M Klemperer; W C Mentzer; F O Smith; K M Sullivan
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.

Authors:  B Eggleston; M Patience; S Edwards; T Adamkiewicz; G R Buchanan; S C Davies; R Dickerhoff; S Donfield; S A Feig; R H Giller; A Haight; J Horan; L L Hsu; N Kamani; P Lane; J E Levine; D Margolis; T B Moore; K Ohene-Frempong; R Redding-Lallinger; I A G Roberts; Z R Rogers; J E Sanders; J P Scott; B Sleight; A A Thompson; K M Sullivan; M C Walters
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

4.  Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.

Authors:  A Cohen; A Rovelli; B Bakker; C Uderzo; M T van Lint; H Esperou; A Gaiero; A D Leiper; R Dopfer; J Y Cahn; F Merlo; H J Kolb; G Socié
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

5.  Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia.

Authors:  M C Walters; M Patience; W Leisenring; Z R Rogers; V M Aquino; G R Buchanan; I A Roberts; A M Yeager; L Hsu; T Adamkiewicz; J Kurtzberg; E Vichinsky; B Storer; R Storb; K M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

Review 6.  Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems.

Authors:  L Adès; P Guardiola; G Sociè
Journal:  Blood Rev       Date:  2002-06       Impact factor: 8.250

Review 7.  Gonadal function and pubertal development after treatment of a childhood malignancy.

Authors:  A Cicognani; A Pasini; A Pession; P Pirazzoli; R Burnelli; E Barbieri; L Mazzanti; E Cacciari
Journal:  J Pediatr Endocrinol Metab       Date:  2003-03       Impact factor: 1.634

8.  Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.

Authors:  C Vermylen; G Cornu; A Ferster; B Brichard; J Ninane; A Ferrant; A Zenebergh; P Maes; C Dhooge; Y Benoit; Y Beguin; M F Dresse; E Sariban
Journal:  Bone Marrow Transplant       Date:  1998-07       Impact factor: 5.483

9.  Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.

Authors:  Françoise Bernaudin; Gérard Socie; Mathieu Kuentz; Sylvie Chevret; Michel Duval; Yves Bertrand; Jean-Pierre Vannier; Karima Yakouben; Isabelle Thuret; Pierre Bordigoni; Alain Fischer; Patrick Lutz; Jean-Louis Stephan; Nathalie Dhedin; Emmanuel Plouvier; Geneviève Margueritte; Dominique Bories; Suzanne Verlhac; Hélène Esperou; Lena Coic; Jean-Paul Vernant; Eliane Gluckman
Journal:  Blood       Date:  2007-07-02       Impact factor: 22.113

10.  Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation.

Authors:  Cécile Brachet; Claudine Heinrichs; Sylvie Tenoutasse; Christine Devalck; Nadira Azzi; Alina Ferster
Journal:  J Pediatr Hematol Oncol       Date:  2007-07       Impact factor: 1.289
  10 in total
  7 in total

1.  A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.

Authors:  Ajay Perumbeti; Tomoyasu Higashimoto; Fabrizia Urbinati; Robert Franco; Herbert J Meiselman; David Witte; Punam Malik
Journal:  Blood       Date:  2009-05-27       Impact factor: 22.113

Review 2.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.

Authors:  Hitomi Hosoya; Jeffrey Levine; Peter Abt; David Henry; David L Porter; Saar Gill
Journal:  Blood Adv       Date:  2018-03-13

Review 3.  Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; John F Tisdale
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

4.  A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Authors:  Shalini Shenoy; Mary Eapen; Julie A Panepinto; Brent R Logan; Juan Wu; Allistair Abraham; Joel Brochstein; Sonali Chaudhury; Kamar Godder; Ann E Haight; Kimberly A Kasow; Kathryn Leung; Martin Andreansky; Monica Bhatia; Jignesh Dalal; Hilary Haines; Jennifer Jaroscak; Hillard M Lazarus; John E Levine; Lakshmanan Krishnamurti; David Margolis; Gail C Megason; Lolie C Yu; Michael A Pulsipher; Iris Gersten; Nancy DiFronzo; Mary M Horowitz; Mark C Walters; Naynesh Kamani
Journal:  Blood       Date:  2016-09-13       Impact factor: 22.113

5.  Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.

Authors:  Shalini Shenoy
Journal:  Ther Adv Hematol       Date:  2013-10

6.  Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.

Authors:  Lakshmanan Krishnamurti; Staci D Arnold; Ann Haight; Allistair Abraham; Gregory Mt Guilcher; Tami John; Nitya Bakshi; Shalini Shenoy; Karen Syrjala; Paul L Martin; Sonali Chaudhury; Gretchen Eames; Olusola Festus Olowoselu; Matthew Hsieh; Josu De La Fuente; Kimberly A Kasow; Elizabeth Stenger; Anne Mertens; Fuad El-Rassi; Peter Lane; Bronwen E Shaw; Lillian Meacham; David Archer
Journal:  JMIR Res Protoc       Date:  2022-07-06

Review 7.  Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.

Authors:  Françoise Bernaudin
Journal:  J Clin Med       Date:  2019-09-22       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.